D Rebounds in Federal FY2000 Budget

Budgets for Top Federal R&D Agencies The U.S. House of Representatives delivered a bumper crop for science in its fiscal year (FY) 2000 budget--but the R&D harvest still has a slight chance to be delayed or threatened by cows. Congressional moos reportedly filled the House chambers after the announcement that Sen. Herb Kohl (D-Wis.) planned to delay voting on a bill that would finalize a $1.8 trillion budget. Kohl's beef had nothing to do with science, but rather, with dairy subsidies that he

Written byPaul Smaglik
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Budgets for Top Federal R&D Agencies

The U.S. House of Representatives delivered a bumper crop for science in its fiscal year (FY) 2000 budget--but the R&D harvest still has a slight chance to be delayed or threatened by cows. Congressional moos reportedly filled the House chambers after the announcement that Sen. Herb Kohl (D-Wis.) planned to delay voting on a bill that would finalize a $1.8 trillion budget. Kohl's beef had nothing to do with science, but rather, with dairy subsidies that he says unfairly help New England farmers while letting Midwestern milkers languish.

But science, at least, hasn't languished in the FY2000 budget proceedings. After summer concerns that R&D could take a several-billion-dollar hit in efforts to keep figures under caps established to meet balanced budget requirements, lawmakers silently let the cap argument slide. "The caps technically exist. In practice, they've been blown," comments Kei Koizumi, the head American ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies